« Previous
Next »
Titles
- M10: bioanalytical method validation and study sample analysis : guidance for industry1
- M4 organization of the Common Technical Document for the Registration of Pharmaceuticals for Human Use1
- M4E(R2): the CTD--efficacy1
- M7(R1) assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk1
- M7(R2) assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk: guidance for industry1
- Manual for public health nurses2
- Manufacturers sharing patient-specific information from medical devices with patients upon request: guidance for industry and Food and Drug Administration staff1
- Measuring the difference: guide to planning and evaluating health information outreach1
- Medical product communications that are consistent with the FDA-required labeling: questions and answers1
- Medical reference data for staff officers1
- Memorandum addressed to the local authorities of the cities, towns, and villages of Tennessee1
- Microdose radiopharmaceutical diagnostic drugs: nonclinical study recommendations1
- Migraine: developing drugs for acute treatment1
- Mixing, diluting, or repackaging biological products outside the scope of an approved biologics license application1
- Multiple endpoints in clinical trials: guidance for industry1